- Home
- Publications
- Publication Search
- Publication Details
Title
Obesity and endocrine-related cancer: The important role of IGF-1
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-01-23
DOI
10.3389/fendo.2023.1093257
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines
- (2022) Angela Ragone et al. Frontiers in Pharmacology
- The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular
- (2022) Junyuan Deng et al. Frontiers in Cell and Developmental Biology
- Dynamics of estrogen-induced ROS and DNA strand break generation in estrogen receptor α-positive breast cancer
- (2022) Shaolong Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fatty Pancreas-Centered Metabolic Basis of Pancreatic Adenocarcinoma: From Obesity, Diabetes and Pancreatitis to Oncogenesis
- (2022) Ming-Ling Chang Biomedicines
- Obesity contributes to the stealth peritoneal dissemination of ovarian cancer: a multi‐institutional retrospective cohort study
- (2022) Shohei Iyoshi et al. Obesity
- Disrupting Insulin and IGF Receptor Function in Cancer
- (2021) Jingran Cao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice
- (2021) Keizo Takenaga et al. Scientific Reports
- Identification of a Resistance Mechanism to IGF-IR Targeting in Human Triple Negative MDA-MB-231 Breast Cancer Cells
- (2021) Jennifer Tsui et al. Biomolecules
- IGF-1R depletion sensitizes colon cancer cell lines to radiotherapy
- (2021) Rui Zong et al. Cancer Biomarkers
- Obesity and mortality among endometrial cancer survivors: A systematic review and meta‐analysis
- (2021) Renée L. Kokts‐Porietis et al. Obesity Reviews
- A phase 1 trial of xentuzumab, an IGF‐neutralizing antibody, in Japanese patients with advanced solid tumors
- (2021) Toshihiko Doi et al. CANCER SCIENCE
- Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial
- (2021) Cindy H Chau et al. ENDOCRINE-RELATED CANCER
- Peri-Prostatic Adipocyte-Released TGFβ Enhances Prostate Cancer Cell Motility by Upregulation of Connective Tissue Growth Factor
- (2021) Evelina La Civita et al. Biomedicines
- Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer
- (2020) J.M. Genkinger et al. ANNALS OF ONCOLOGY
- Metabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin
- (2020) Lisa D. Yee et al. Frontiers in Endocrinology
- Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
- (2020) Johann de Bono et al. BRITISH JOURNAL OF CANCER
- Insulin-like growth factor-1 receptor expression and disease recurrence and survival in patients with resected pancreatic ductal adenocarcinoma
- (2020) Chunxia Du et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer
- (2020) Qing Cai et al. Cells
- Does increased body mass index lead to elevated prostate cancer risk? It depends on waist circumference
- (2020) Jin Bong Choi et al. BMC CANCER
- Assessment of expression levels of leptin and leptin receptor as potential biomarkers for risk of prostate cancer development and aggressiveness
- (2020) Hala Fawzy Mohamed Kamel et al. Cancer Medicine
- Circulating Insulin-Like Growth Factor-1 and Risk of Total and 19 Site-Specific Cancers: Cohort Study Analyses from the UK Biobank
- (2020) Frank Qian et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer
- (2020) Junjie Huang et al. GASTROENTEROLOGY
- Insulin‐like growth factor 1 promotes proliferation and invasion of papillary thyroid cancer through the STAT3 pathway
- (2020) Li Yang et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis
- (2020) Arathi Rajan et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Obesity-related protein biomarkers for predicting breast cancer risk: an overview of systematic reviews
- (2020) Xueyao Wu et al. Breast Cancer
- Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors BMS-754807 and OSI-906 on Human Cancer Cell Lines
- (2020) María Fuentes-Baile et al. Cancers
- Estradiol induces cell proliferation in MCF‑7 mammospheres through HER2/COX‑2
- (2019) Chin‑Hu Wu et al. Molecular Medicine Reports
- Circulating adipokines and risk of obesity related cancers: A systematic review and meta-analysis
- (2019) Yeong Sook Yoon et al. Obesity Research & Clinical Practice
- Role of Adiponectin in prostate cancer
- (2019) Xiaobo Hu et al. International Braz J Urol
- Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment
- (2019) Livia Manzella et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating IGF-1 promotes prostate adenocarcinoma via FOXO3A/BIM signaling in a double-transgenic mouse model
- (2019) Shuang Wang et al. ONCOGENE
- Therapeutic Targeting of the IGF Axis
- (2019) Eliot Osher et al. Cells
- Pre-diagnosis body mass index, physical activity and ovarian cancer mortality
- (2019) Abigail S. Zamorano et al. GYNECOLOGIC ONCOLOGY
- IGF‐1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER‐positive breast cancer
- (2019) Dinja T. Kruger et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of overweight and obesity on U.S. papillary thyroid cancer incidence trends (1995-2015)
- (2019) Cari M Kitahara et al. JNCI-Journal of the National Cancer Institute
- Peri-prostatic adipose tissue: the metabolic microenvironment of prostate cancer
- (2018) Zeyad D. Nassar et al. BJU INTERNATIONAL
- Periprostatic fat tissue transcriptome reveals a signature diagnostic for high-risk prostate cancer
- (2018) Stefano Mangiola et al. ENDOCRINE-RELATED CANCER
- Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer
- (2018) Loredana Mauro et al. FASEB JOURNAL
- A phase 2 study of OSI-906 (linsitinib, an insulin-like growth factor receptor-1 inhibitor) in patients with asymptomatic or mildly symptomatic (non-opioid requiring) metastatic castrate resistant prostate cancer (CRPC)
- (2018) Pedro Barata et al. INVESTIGATIONAL NEW DRUGS
- Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer
- (2018) Lucy Ireland et al. ONCOGENE
- Leptin promotes the growth of breast cancer by upregulating the Wnt/β‑catenin pathway
- (2018) Xi Liang et al. Experimental and Therapeutic Medicine
- Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis
- (2018) Miho Akimoto et al. Cell Death & Disease
- Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database
- (2018) Stephen J. Freedland et al. BJU INTERNATIONAL
- Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine
- (2018) Katharina Nimptsch et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer
- (2018) Masafumi Iida et al. Breast Cancer
- Role of ERα in Mediating Female Uterine Transcriptional Responses to IGF1
- (2017) Sylvia C Hewitt et al. ENDOCRINOLOGY
- Modulation of SHBG binding to testosterone and estradiol by sex and morbid obesity
- (2017) María del Mar Grasa et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Leptin induces CREB-dependent aromatase activation through COX-2 expression in breast cancer cells
- (2017) Hyung Gyun Kim et al. FOOD AND CHEMICAL TOXICOLOGY
- Systemic analysis of different colorectal cancer cell lines and TCGA datasets identified IGF-1R/EGFR-PPAR-CASPASE axis as important indicator for radiotherapy sensitivity
- (2017) Lin Chen et al. GENE
- Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity–breast cancer link
- (2017) H Zahid et al. INTERNATIONAL JOURNAL OF OBESITY
- Estrogen Metabolism in Abdominal Subcutaneous and Visceral Adipose Tissue in Postmenopausal Women
- (2017) Natalia Hetemäki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- IGF-binding proteins
- (2017) L A Bach JOURNAL OF MOLECULAR ENDOCRINOLOGY
- The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study
- (2017) Robert Carreras-Torres et al. JNCI-Journal of the National Cancer Institute
- Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgery
- (2017) Kieran J. Breen et al. PROSTATE
- Periprostatic adipose inflammation is associated with high-grade prostate cancer
- (2017) A Gucalp et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Leptin is overexpressed in the tumor microenvironment of obese patients with estrogen receptor positive breast cancer
- (2017) Mohamed Hosney et al. Experimental and Therapeutic Medicine
- Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth
- (2017) Fanuel Messaggio et al. Oncotarget
- The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study
- (2017) Robert Carreras-Torres et al. JNCI-Journal of the National Cancer Institute
- Phase II randomized study of the IGF-1R pathway modulator AXL1717 compared to docetaxel in patients with previously treated, locally advanced or metastatic non-small cell lung cancer
- (2016) Michael Bergqvist et al. ACTA ONCOLOGICA
- Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors
- (2016) Melissa A. Merritt et al. CANCER CAUSES & CONTROL
- Does IGF-1 play a role in the biology of endometrial cancer?
- (2016) Dominika Majchrzak-Baczmańska et al. Ginekologia Polska
- The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels
- (2016) Elisenda Alsina-Sanchis et al. INTERNATIONAL JOURNAL OF CANCER
- Aromatase expression and regulation in breast and endometrial cancer
- (2016) Hong Zhao et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- KRAS-related proteins in pancreatic cancer
- (2016) Karen M. Mann et al. PHARMACOLOGY & THERAPEUTICS
- Leptin-Notch signaling axis is involved in pancreatic cancer progression
- (2016) Adriana Harbuzariu et al. Oncotarget
- Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy
- (2015) W. J. Gradishar et al. CLINICAL CANCER RESEARCH
- Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells
- (2015) Loredana Mauro et al. FASEB JOURNAL
- Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
- (2015) Martin Fassnacht et al. LANCET ONCOLOGY
- The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise
- (2015) S. Schmidt et al. Obesity Reviews
- Modulation of the Leptin Receptor Mediates Tumor Growth and Migration of Pancreatic Cancer Cells
- (2015) Alisha M. Mendonsa et al. PLoS One
- Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women
- (2015) Sumie Kato et al. Oncotarget
- Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk
- (2015) Marian L. Neuhouser et al. JAMA Oncology
- Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis
- (2015) Isabel Heidegger et al. Oncotarget
- Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
- (2014) D. S. M. Chan et al. ANNALS OF ONCOLOGY
- Combination of the mTOR Inhibitor Ridaforolimus and the Anti-IGF1R Monoclonal Antibody Dalotuzumab: Preclinical Characterization and Phase I Clinical Trial
- (2014) S. Di Cosimo et al. CLINICAL CANCER RESEARCH
- Obesity and the reproductive system disorders: epigenetics as a potential bridge
- (2014) Ana B. Crujeiras et al. HUMAN REPRODUCTION UPDATE
- Estradiol Affects Extracellular Leptin:Adiponectin Ratio in Human Breast Tissue in Vivo
- (2014) Vivian Morad et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial
- (2014) Arun Rajan et al. LANCET ONCOLOGY
- Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma
- (2014) Tiehong Zhang et al. Scientific Reports
- Insulin-Like Growth Factor 1 Receptor Promotes the Growth and Chemoresistance of Pancreatic Cancer
- (2013) Xiaodong Tian et al. DIGESTIVE DISEASES AND SCIENCES
- An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours
- (2013) P. Schöffski et al. EUROPEAN JOURNAL OF CANCER
- A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma
- (2013) Ghassan K. Abou-Alfa et al. JOURNAL OF HEPATOLOGY
- Pharmacodynamic and Antineoplastic Activity of BI 836845, a Fully Human IGF Ligand-Neutralizing Antibody, and Mechanistic Rationale for Combination with Rapamycin
- (2013) K. Friedbichler et al. MOLECULAR CANCER THERAPEUTICS
- Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group
- (2013) Brenda Weigel et al. PEDIATRIC BLOOD & CANCER
- Epitope-Specific Mechanisms of IGF1R Inhibition by Ganitumab
- (2013) Frank J. Calzone et al. PLoS One
- Interaction between IGF-IR and ER Induced by E2 and IGF-I
- (2013) Zhenghong Yu et al. PLoS One
- IGF-IR Promotes Prostate Cancer Growth by Stabilizing α5β1 Integrin Protein Levels
- (2013) Aejaz Sayeed et al. PLoS One
- A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors
- (2012) Diane L. Reidy-Lagunes et al. CANCER
- Obesity and Prostate Cancer: Weighing the Evidence
- (2012) Emma H. Allott et al. EUROPEAN UROLOGY
- KRASG12D- and BRAFV600E-Induced Transformation of Murine Pancreatic Epithelial Cells Requires MEK/ERK-Stimulated IGF1R Signaling
- (2012) V. A. Appleman et al. MOLECULAR CANCER RESEARCH
- Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes
- (2011) Rinat Yerushalmi et al. BREAST CANCER RESEARCH AND TREATMENT
- Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma
- (2011) Matias E. Valsecchi et al. CANCER
- Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma
- (2011) Heribert Juergens et al. JOURNAL OF CLINICAL ONCOLOGY
- Leptin enhances growth inhibition by cAMP elevating agents through apoptosis of MDA-MB-231 breast cancer cells
- (2010) Silvio Naviglio et al. CANCER BIOLOGY & THERAPY
- Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells
- (2010) Silvio Naviglio et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer
- (2010) Robert G. Maki JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation